Gemzar for Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 7
Volume 5
Issue 7

INDIANAPOLIS--Eli Lilly and Company's Gemzar (gemcitabine) is now available for use in the treatment of advanced pancreatic cancer.

INDIANAPOLIS--Eli Lilly and Company's Gemzar (gemcitabine) isnow available for use in the treatment of advanced pancreaticcancer.

"As the first new treatment for pancreatic cancer in severaldecades, Gemzar represents hope for patients and a breakthroughfor Lilly scientists," said August M. Watanabe, MD, executivevice president of the company.

Gemzar, a nucleoside analog, is the first chemotherapy agent toreceive FDA clearance based on a unique clinical endpoint--clinicalbenefit response--designed to objectively assess the effect ofthe drug on measured disease-related symptoms. In two clinicaltrials, about one quarter of patients treated with Gemzar demonstratedimprovement in symptoms.

Gemzar is indicated as first-line treatment for patients withlocally advanced (nonresectable stage II or III) or metastatic(stage IV) adenocarcinoma of the pancreas, and is also indicatedfor patients previously treated with fluorouracil.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
According to Benjamin Golas, MD, PIPAC is emerging as minimally invasive laparoscopic approach for patients with peritoneal carcinomatosis.
According to Ronan J. Kelly, deciding whether to give nivolumab- or durvalumab-based regimens in gastric cancers may rely on a patient’s frailty.
Five-year follow-up revealed that patients treated with nivolumab vs placebo in the phase 3 CheckMate 577 trial experienced a “doubling” of survival.
Patients treated with nivolumab in the phase 3 CheckMate 577 trial were less likely to experience progression-related treatment discontinuation vs placebo.
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
Related Content